Calcium responses are altered in fibroblasts from Alzheimer's patients and pre-symptomatic PS1 carriers: A potential tool for early diagnosis

Alzheimer's Reports

Volumn 3, Issue 5-6, 2000, Pages 305-312

  Etcheberrigaray, René ^a,b   Bhagavan, Seetha ^a   Bank, Barry ^a   Alkon, Daniel L ^a  

^a NeuroLogic Inc   (United States)

^b Blanchette Rockefeller Neurosciences Institute   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 23044523116     PISSN: 14616130     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Baker AC, Ko L-W and Blass JP (1988). Systemic manifestations of Alzheimer's disease. Age 11,60-65.
2. Bhagavan S, Ibarreta D, Ma D et al. (1998). Restoration of TEA-induced calcium responses in fibroblasts from Alzheimer's disease patients by a PKC activator. Neurobiol Dis 5,177-187.
3. Bondy B, Hofmann M, Muller-Spahn F étal. (1996). The PHA-induced calcium signal in lymphocytes is altered after blockade of K channels in Alzheimer's disease. JPsychiatr Res 30,217-227.
4. ConnoIIy GP (1998). Fibroblast models of neurological disorders: fluorescence measurement studies. TIPS 19,171-177.
5. de Suva HA, Aronson JK, Grahame-Smith DG et aJ. (1998) Abnormal function of potassium channels in platelets of patients with Alzheimer's disease. Lancet 352,1590-1593.
6. Etcheberrigaray R, Ito E, Oka K et al. (1993). Potassium channel dysfunction in fibroblasts identifies patients with Alzheimer disease. Proc NatlAcad Sei USA 90, 8209-8213.
7. Etcheberrigaray R et al. (1994). Soluble β-amyloid induction of Alzheimer's phenotype for human fibroblasts K channels. Science 264, 276-279.
8. Etcheberrigaray R, Hirashima N, Nee et al. (1998). Calcium responses in fibroblasts from asymptomatic members of Alzheimer's disease families. Neurobiol Dis 5,37-45.
9. Gasparini L, Racchi M, Binetti G eraJ. (1997). Peripheral markers in testing pathophysiological hypotheses and diagnosing Alzheimer's disease. FASEB J 12,17-34.
10. Gibson G, Martins R, Blass J et al. (1996). Altered oxidation and signal transduction systems in fibroblasts from Alzheimer patients. Life Sciences 59,477-489.
11. Gibson GE, Vestling M, Zhang H étal. (1997). Abnormalities in Alzheimer's disease fibroblasts bearing the APP670/671 mutation. Neurobiol Aging 6,573-580.
12. + current in rat hippocampal neurons. Biophys J 70, 296-304.
13. Hardy J (1997). Amyloid, the presenilins and Alzheimer's disease. TINS 20,154-159.
14. Hirashima N, Etcheberrigaray R, Bergamaschi S et al. (1996). Calcium responses in human fibroblasts: a diagnostic molecular profile for Alzheimer's disease. Neurobiol Aging 17,549-555.
15. Hock C (1998). Biological markers of Alzheimer's disease. Neurobiol Aging'19,149-151.
16. 2+-mobilization is altered in fibroblasts from patients with Alzheimer's disease. Proc NatlAcad Sei USA 91,534-538.
17. Keller JN, Guo Q, Holstberg FW et al. (1998). Increased sensitivity to mitochondria! toxin-induced apoptosis in neural cells expressing mutant presenilin-1 is linked to perturbed calcium homeostasis and enhanced oxyradical production. JNeurosci 18,4439-4450.
18. MattsonMP,GuoQ, FurukawaK etal.(1998).Presenilins,theendoplasmic reticulum, and neuronal apoptosis in Alzheimer's disease. J Neurochem70,1-14.
19. Motulsky H (1995). Interpreting lab tests: Introduction to Bayesian thinking. In: Intuitive Biostatistics. Oxfordllniversity Press, Oxford: pp129-148
20. National Institute of Aging (1994). Catalog of Cell Lines.
21. Nee LE, Polinsky RJ and Eldridge R (1983). A family with histologically confirmed Alzheimer's disease. Arch Neurol40,203-208.
22. Scheuner D, Eckman C, Jensen M ef al. (1996) Secreted amyloid βprotein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease. Nature Med2, 864-870.
23. Scott RB (1993). Extraneuronal manifestations of Alzheimer's disease. JAGS 41,268-276.
24. Tanzi RE, Kovacs DM, Kim ef aJ. (1996). The gene defects responsible for familial Alzheimer's disease. Neurobiol Dis 3,159-168.
25. The Ronald and Nancy Reagan Research Institute of the Alzheimer's Association and the National Institute on Aging Working Groups (1998). Consensus report of the Working Group on: Molecular and Biochemical markers of Alzheimer's disease. Neurobiol Agmg19,109-116.
26. Thomas AP and Delaville F (1991 ). The use of fluorescent indicators for measurements of cytosolic-free calcium concentration in cell populations and single cells. In: Cellular Calcium. McCormack JG and Cobbold PH, eds. IRL Press: pp. 1-54.
27. Vestling M, Cedazo-Minguez A, Adem A et al. (1999). Protein kinase C levels and amyloid processing in skin fibroblasts from sporadic and familial Alzheimer's disease cases. Biochem Biophys Acta 145,341-350.